Skip to main content
Clinical Trials/JPRN-UMIN000031703
JPRN-UMIN000031703Completed未知

Oral Beclometasone dipropionate for for gut GVHD - BDP for gut GVHD

Department of Pediatrics, University of Ryukyus, hospital0 sites1 target enrollmentStarted: March 15, 2018Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
1

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
11years-old to 11years-old (—)
Sex
Male

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • no active cytomegalovirus (CMV) infection and no CMV antigenemia for confirmed endoscopically gut GVHD

Investigators

Sponsor
Department of Pediatrics, University of Ryukyus, hospital

Similar Trials

Completed
Not Applicable
Oral beclomethasone dipropionate treatment for gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantatioPatients with symptoms of acute gastrointestinal GVHD after allo-HSCT
JPRN-UMIN000027026Tokyo Women's Medical University, Department of Hematology5
Active, not recruiting
Not Applicable
Efficacy and safety of beclometasone dipropionate (BDP) gastro-resistant prolonged release tablets (CHF1514) compared to oral steroid (prednisone) in an 8-week treatment period in patients with active moderate ulcerative colitis. A multicentre, randomised, controlled, double blind, parallel group study. Beta study - BETAMild moderate active ulcerative colitisMedDRA version: 9.1Level: LLTClassification code 10009900Term: Colitis ulcerative
EUCTR2006-004230-32-ITCHIESI300
Completed
Not Applicable
The efficacy and safety of oral Beclomethasone dipropionate (BDP) in patients with gastrointestinal acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation FBMTG BDP17Hematologic disorders Gastrointestinal acute GVHD
JPRN-UMIN000025116FBMTG35
Completed
Not Applicable
The efficacy and safety of oral Beclomethasone dipropionate (BDP) in patients with gastrointestinal acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantatioHematologic disorders Gastrointestinal acute GVHD
JPRN-UMIN000010750Fukuoka Blood and Marrow Transplantation Group35
Completed
Phase 1
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonChronic Myeloproliferative DisordersGestational Trophoblastic TumorGraft Versus Host DiseaseKidney CancerMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesTesticular Germ Cell TumorBreast CancerOvarian CancerLymphomaLeukemiaNeuroblastoma
NCT00010283Fred Hutchinson Cancer Center
Oral Beclometasone dipropionate for for... | Clinical Trial